Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody.
J Dermatol
; 49(9): e311-e312, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35546739
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatomyositis
Type of study:
Diagnostic_studies
Limits:
Aged80
/
Female
/
Humans
Language:
En
Journal:
J Dermatol
Year:
2022
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom